Mektup


DOI :10.26650/IUITFD.1133431   IUP :10.26650/IUITFD.1133431    Tam Metin (PDF)

THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS

Pathum SookaromdeeViroj Wiwanitkit

.


PDF Görünüm

Referanslar

  • 1. Hsia W. Emerging new coronavirus infection in Wuhan, China: situation in early 2020. Case Study Case Rep 2020;10:8-9. google scholar
  • 2. Soleimanpour S, Yaghoubi A. COVID-19 vaccine: where are we now and where should we go? Expert Rev Vaccines 2021;20(1):23-44. [CrossRef] google scholar
  • 3. Shekhar R, Garg I, Pal S, Kottewar S, Sheikh AB. COVID-19 Vaccine booster: to boost or not to boost. Infect Dis Rep 2021;13(4):924-929. [CrossRef] google scholar
  • 4. Krause PR, Fleming TR, Peto R, Longini IM, Figueroa JP, Sterne JAC, et al. Considerations in boosting COVID-19 vaccine immune responses. Lancet 2021;398(10308):1377-80. [CrossRef] google scholar
  • 5. Mahase E. COVID-19: third vaccine dose boosts immune response but may not be needed, say researchers. BMJ 2021;373:n1659. [CrossRef] google scholar
  • 6. Burki TK. Fourth dose of COVID-19 vaccines in Israel. Lancet Respir Med 2022;10(2):e19. [CrossRef] google scholar
  • 7. Abedon AT, Teles MS, Alejo JL, Kim JD, Mitchell J, Chiang TPY, et al. Improved antibody response after a fifth dose of a SARS-CoV-2 vaccine in solid organ transplant recipients: a case series. Transplantation 2022;106(5):e262-3. [CrossRef] google scholar
  • 8. Osmanodja B, Ronicke S, Budde K, Jens A, Hammett C, Koch N, et al. Serological response to three, four and five doses of SARS-CoV-2 vaccine in kidney transplant recipients. J Clin Med 2022;11(9):2565. [CrossRef] google scholar
  • 9. Sookaromdee P, Wiwanitkit V. New COVID-19 vaccines, its cost and shelf life: a cost effectiveness analysis. Arch Med Res 2021;52(4):453. [CrossRef] google scholar
  • 10. Yasri S, Wiwanitkit V. Expected response to the additional third dose of COVID-19 vaccine based on different complete standard vaccination background. Int J Physiol Pathophysiol Pharmacol 2022;14(1):1-3. google scholar

Atıflar

Biçimlendirilmiş bir atıfı kopyalayıp yapıştırın veya seçtiğiniz biçimde dışa aktarmak için seçeneklerden birini kullanın


DIŞA AKTAR



APA

Sookaromdee, P., & Wiwanitkit, V. (2019). THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi, 0(0), -. https://doi.org/10.26650/IUITFD.1133431


AMA

Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi. 2019;0(0):-. https://doi.org/10.26650/IUITFD.1133431


ABNT

Sookaromdee, P.; Wiwanitkit, V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi, [Publisher Location], v. 0, n. 0, p. -, 2019.


Chicago: Author-Date Style

Sookaromdee, Pathum, and Viroj Wiwanitkit. 2019. “THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” İstanbul Tıp Fakültesi Dergisi 0, no. 0: -. https://doi.org/10.26650/IUITFD.1133431


Chicago: Humanities Style

Sookaromdee, Pathum, and Viroj Wiwanitkit. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” İstanbul Tıp Fakültesi Dergisi 0, no. 0 (Oct. 2022): -. https://doi.org/10.26650/IUITFD.1133431


Harvard: Australian Style

Sookaromdee, P & Wiwanitkit, V 2019, 'THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS', İstanbul Tıp Fakültesi Dergisi, vol. 0, no. 0, pp. -, viewed 6 Oct. 2022, https://doi.org/10.26650/IUITFD.1133431


Harvard: Author-Date Style

Sookaromdee, P. and Wiwanitkit, V. (2019) ‘THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS’, İstanbul Tıp Fakültesi Dergisi, 0(0), pp. -. https://doi.org/10.26650/IUITFD.1133431 (6 Oct. 2022).


MLA

Sookaromdee, Pathum, and Viroj Wiwanitkit. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS.” İstanbul Tıp Fakültesi Dergisi, vol. 0, no. 0, 2019, pp. -. [Database Container], https://doi.org/10.26650/IUITFD.1133431


Vancouver

Sookaromdee P, Wiwanitkit V. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS. İstanbul Tıp Fakültesi Dergisi [Internet]. 6 Oct. 2022 [cited 6 Oct. 2022];0(0):-. Available from: https://doi.org/10.26650/IUITFD.1133431 doi: 10.26650/IUITFD.1133431


ISNAD

Sookaromdee, Pathum - Wiwanitkit, Viroj. THE EXPECTED SEROPROTECTION RATE AFTER THE SIXTH DOSE OF THE COVID-19 VACCINE: A NOTE FROM A CLINICAL MODEL ON KIDNEY TRANSPLANT RECIPIENTS”. İstanbul Tıp Fakültesi Dergisi 0/0 (Oct. 2022): -. https://doi.org/10.26650/IUITFD.1133431



ZAMAN ÇİZELGESİ


Gönderim20.06.2022
Kabul04.07.2022
Çevrimiçi Yayınlanma02.08.2022

LİSANS


Attribution-NonCommercial (CC BY-NC)

This license lets others remix, tweak, and build upon your work non-commercially, and although their new works must also acknowledge you and be non-commercial, they don’t have to license their derivative works on the same terms.


PAYLAŞ




İstanbul Üniversitesi Yayınları, uluslararası yayıncılık standartları ve etiğine uygun olarak, yüksek kalitede bilimsel dergi ve kitapların yayınlanmasıyla giderek artan bilimsel bilginin yayılmasına katkıda bulunmayı amaçlamaktadır. İstanbul Üniversitesi Yayınları açık erişimli, ticari olmayan, bilimsel yayıncılığı takip etmektedir.